Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma
出版年份 2023 全文链接
标题
Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma
作者
关键词
-
出版物
BIOFACTORS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-03
DOI
10.1002/biof.2012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune checkpoint receptors in autoimmunity
- (2023) Kelly P Burke et al. CURRENT OPINION IN IMMUNOLOGY
- A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
- (2023) Runjie Song et al. Molecular Cancer
- Clinical application study on miR-98–5p as a prognostic biomarker in hepatocellular carcinoma
- (2023) Peng-tian Ji et al. Clinics and Research in Hepatology and Gastroenterology
- Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion
- (2023) Jakob G. Habib et al. Frontiers in Immunology
- Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
- (2023) Tomofumi Watanabe et al. CANCER SCIENCE
- Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
- (2023) Philippe Merle et al. DIGESTIVE AND LIVER DISEASE
- Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment
- (2023) Muhammad Joan Ailia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination immunotherapy for hepatocellular carcinoma
- (2023) Lorenza Rimassa et al. JOURNAL OF HEPATOLOGY
- Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment
- (2023) Parviz Azimnasab-sorkhabi et al. MOLECULAR BIOLOGY REPORTS
- The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
- (2023) Sruthi Vijaya Retnakumar et al. PHARMACOLOGY & THERAPEUTICS
- Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
- (2023) Mona Meng Wang et al. BRITISH JOURNAL OF CANCER
- The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer
- (2023) Ahmed Hjazi et al. PATHOLOGY RESEARCH AND PRACTICE
- Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
- (2022) Chupeng Hu et al. HEPATOLOGY
- Eliminating METTL1 ‐mediated accumulation of PMN‐MDSCs prevents HCC recurrence after radiofrequency ablation
- (2022) Xuezhen Zeng et al. HEPATOLOGY
- Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
- (2022) Karl L. Banta et al. IMMUNITY
- Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
- (2022) Mahsa Pourhamzeh et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Association of Gut Microbiome and Primary Liver Cancer: A Two‐sample Mendelian Randomization and Case‐control Study
- (2022) Jun Ma et al. LIVER INTERNATIONAL
- Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism
- (2022) Ding-Ping Chen et al. Frontiers in Immunology
- Designing Cancer Immunotherapies That Engage T Cells and NK Cells
- (2022) Oleksandr Kyrysyuk et al. Annual Review of Immunology
- Anti-Claudin18.2-IL-21 fusion protein bifunctional molecule has more powerful anti-tumor effect and better safety
- (2022) Yangyihua Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response
- (2022) Bufu Tang et al. Advanced Science
- Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2021) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
- (2021) Marina K. Holz et al. CELL
- Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression
- (2021) Hong-Yu Zhang et al. Frontiers in Oncology
- TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
- (2021) Zhouhong Ge et al. Cellular and Molecular Gastroenterology and Hepatology
- PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
- (2021) Mohammad Jalili-Nik et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
- (2021) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of an Indomethacin Oral Spray on Pain Due to Oral Mucositis in Cancer Patients Treated With Radiotherapy and Chemotherapy: A Double-Blind, Randomized, Placebo-Controlled Trial (JORTC-PAL04)
- (2021) Hiroka Nagaoka et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Emerging role of natural products in cancer immunotherapy
- (2021) Songtao Dong et al. Acta Pharmaceutica Sinica B
- TGF-β1 Induces Immune Escape by Enhancing PD-1 and CTLA-4 Expression on T Lymphocytes in Hepatocellular Carcinoma
- (2021) Shixiang Bao et al. Frontiers in Oncology
- miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)
- (2021) Weifeng Huang et al. Journal of Gastrointestinal Oncology
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- The foundations of immune checkpoint blockade and the ipilimumab approval decennial
- (2021) Alan J. Korman et al. NATURE REVIEWS DRUG DISCOVERY
- CTLA-4: From mechanism to autoimmune therapy
- (2020) Arezoo Hosseini et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes
- (2020) Asmaa M. Zahran et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells
- (2020) Yihe Yan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatocellular Carcinoma Cells Upregulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice
- (2020) David Kung-Chun Chiu et al. GASTROENTEROLOGY
- Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection
- (2020) Li Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
- (2020) Xiao-Yong Huang et al. Molecular Cancer
- Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
- (2020) Federico Piñero et al. Cells
- Clinical Challenges of Immune Checkpoint Inhibitors
- (2020) Maria de Miguel et al. CANCER CELL
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
- (2020) Peng-Fei Zhang et al. Molecular Cancer
- Relationship between IL10 and PD-L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines
- (2020) Qian Qian et al. Biomed Research International
- IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
- (2020) Wenjie Zhang et al. Journal for ImmunoTherapy of Cancer
- Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma
- (2020) Julien Calderaro Hepatobiliary Surgery and Nutrition
- TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells
- (2020) Takuya Sekine et al. Science Immunology
- Golgi Membrane Protein 1 (GOLM1) Promotes Growth and Metastasis of Breast Cancer Cells via Regulating Matrix Metalloproteinase-13 (MMP13)
- (2019) Rui Zhang et al. MEDICAL SCIENCE MONITOR
- Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy
- (2019) Reena Varkey et al. PLoS One
- PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
- (2019) Arash Salmaninejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
- (2019) Hui Li et al. GASTROENTEROLOGY
- Depression promotes hepatocellular carcinoma progression through a glucocorticoid-mediated upregulation of PD-1 expression in tumor-infiltrating NK cells
- (2019) Yawei Zhao et al. CARCINOGENESIS
- Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
- (2019) Xiuqi Wu et al. MOLECULAR THERAPY
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and histological correlations in liver cancer
- (2019) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma
- (2019) Xiaochen Wang et al. JOURNAL OF HEPATOLOGY
- Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk
- (2019) Jing Yang et al. MEDICINE
- M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling
- (2019) Zhaoyun Zong et al. Frontiers in Immunology
- Dual PD ‐1 and VEGFR ‐2 blockade promotes vascular normalization and enhances anti‐tumor immune responses in HCC
- (2019) Kohei Shigeta et al. HEPATOLOGY
- Hepatocellular Carcinoma Growth Retardation and PD-1 Blockade Therapy Potentiation with Synthetic High-density Lipoprotein
- (2019) Junyang Wang et al. NANO LETTERS
- Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
- (2019) Guoyi Wu et al. Cancer Medicine
- Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas
- (2019) Yi-Wen Hsiao et al. Genes
- Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma
- (2019) Jingkai Xu et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- Association of CTLA‐4 , TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma
- (2019) Jia‐jia Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- (2019) Jiaqiang Ma et al. Journal for ImmunoTherapy of Cancer
- EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
- (2019) Gang Xiao et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy of Hepatocellular Carcinoma with Magnetic PD-1 Peptide-Imprinted Polymer Nanocomposite and Natural Killer Cells
- (2019) Mei-Hwa Lee et al. Biomolecules
- Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma
- (2018) Furong Liu et al. BULLETIN DU CANCER
- Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
- (2018) Zachary J. Brown et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
- (2018) Eric Wehrenberg-Klee et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- AMPK: Sensing Glucose as well as Cellular Energy Status
- (2018) Sheng-Cai Lin et al. Cell Metabolism
- Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
- (2018) Marianne Ziol et al. HEPATOLOGY
- Immune checkpoint blockade for the treatment of human hepatocellular carcinoma
- (2018) Naoshi Nishida et al. HEPATOLOGY RESEARCH
- Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
- (2018) Caroline Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis
- (2018) Xiao-Lin Xu et al. RADIOLOGY
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis
- (2018) Xiaoli Yang et al. Cell Death & Disease
- Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma
- (2018) Kanghua Huang et al. MEDICAL SCIENCE MONITOR
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy
- (2018) Zeli Yin et al. Molecular Cancer
- Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
- (2018) Xingliang Guo et al. Frontiers in Pharmacology
- Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1
- (2017) Hui Li et al. HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
- (2017) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4
- (2017) Xin Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
- (2017) W. K. Eddie Ip et al. SCIENCE
- TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
- (2017) Nicholas A. Manieri et al. TRENDS IN IMMUNOLOGY
- PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
- (2017) Maria Gato-Cañas et al. Cell Reports
- High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
- (2016) Rui Kuai et al. ACS Nano
- Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
- (2016) Oxana V. Makarova-Rusher et al. CANCER
- GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis
- (2016) Qing-Hai Ye et al. CANCER CELL
- Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
- (2016) Jiang Chen et al. Oncotarget
- Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma
- (2015) Pingbo Xu et al. EXPERIMENTAL CELL RESEARCH
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
- (2014) Raksha Mudbhary et al. CANCER CELL
- Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
- (2014) Johannes Landskron et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The PD-1/PD-Ls pathway and autoimmune diseases
- (2014) Suya Dai et al. CELLULAR IMMUNOLOGY
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis
- (2014) Ole Helm et al. INTERNATIONAL JOURNAL OF CANCER
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Insight into nanoparticle cellular uptake and intracellular targeting
- (2014) Basit Yameen et al. JOURNAL OF CONTROLLED RELEASE
- The Common -Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
- (2014) A. L. Kinter et al. JOURNAL OF IMMUNOLOGY
- A preventable cancer
- (2014) Lucas Laursen NATURE
- Human CD14+CTLA-4+regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma
- (2013) Yanmei Han et al. HEPATOLOGY
- Association between CTLA-4 60G/A and -1661A/G Polymorphisms and the Risk of Cancers: A Meta-Analysis
- (2013) Qing Yan et al. PLoS One
- CTLA4-Ig Relieves Inflammation in Murine Models of Coxsackievirus B3-Induced Myocarditis
- (2012) Bo Han et al. CANADIAN JOURNAL OF CARDIOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3
- (2012) Jiajie Hou et al. HEPATOLOGY
- Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
- (2012) Alexander Pedroza-Gonzalez et al. HEPATOLOGY
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Anti-oncogenic potential of the eIF4E-binding proteins
- (2012) Y Martineau et al. ONCOGENE
- Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma
- (2012) XIU-CHENG PAN et al. Oncology Letters
- Epidemiology and Surveillance of Hepatocellular Carcinoma
- (2012) Do Young Kim et al. Liver Cancer
- Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C
- (2011) Richard K Sterling et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue
- (2011) Yusuke Shintani et al. ATHEROSCLEROSIS
- Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth
- (2011) Takayuki Kogure et al. HEPATOLOGY
- CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers—hepatocellular carcinoma and cervical cancer
- (2010) Lingmin Hu et al. HUMAN IMMUNOLOGY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started